Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment

Diabetes

Volumn 46, Issue 2, 1997, Pages 265-270

  Anderson Jr , James H ^a   Brunelle, Rocco L ^a   Koivisto, Veikko A ^b   Pfützner, Andreas ^a   Trautmann, Michael E ^a   Vignati, Louis ^a   DiMarchi, Richard ^a  

^a ELI LILLY AND COMPANY   (United States)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HUMAN INSULIN; HUMULIN U; INSULIN DERIVATIVE; INSULIN LISPRO; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; FEMALE; FLU LIKE SYNDROME; HEADACHE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PHARYNGITIS; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS;

EID: 0030915548     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.2.265     Document Type: Article

References (35)

1. Malherbe C, de Gasparo M, de Hertogh R, Hoet JJ: Circadian variations of blood sugar and plasma insulin levels in man. Diabetologia 5:397-404, 1969
2. Muhlhauser I, Bruckner I, Berger M, Cheta D, Jörgens V, Ionescu-Tirgoviste C, Scholz V, Mincu I: Evaluation of an intensified insulin treatment and teaching programme as routine management of type I (insulin-dependent) diabetes: the Bucharest-Düsseldorf study. Diabetologia 30:681-690, 1987
3. The DCCT Research Group: Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care 18:1415-1427, 1995
4. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV: Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37:901-907, 1988
5. Heller SR, Creyer PE: Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 40:223-226, 1991
6. Dagogo-Jack SE, Craft S, Cryer PE: Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. J Clin Invest 91:819-828, 1993
7. Pramming S, Thorsteinsson B, Bendtson I, Ronn B, Binder C: Nocturnal hypoglycemia in patients receiving conventional treatment with insulin. Br Med J 291:376-379, 1985
8. Dimitriadis G, Gerich J: Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 6:374-377, 1983
9. Lean MEJ, Ng LL, Tennison BR: Interval between insulin injection and eating in relation to blood glucose control in adult diabetics. Br Med J 290:105-108, 1985
10. American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 18 (Suppl. 1):8-15, 1995
11. Jørgensen LN, Nielsen FS: Timing of pre-meal insulins in diabetic patients on a multiple daily injection regimen: a questionnaire study (Abstract). Diabetologia 33:A116, 1990
12. B28) in healthy subjects. Diabetes Care 14:1057-1065, 1991
13. DiMarchi RD, Mayer JP, Fan L, Brems DN, Frank BH, Green LK, Hoffmann JA, Howey DC, Long HB, Shaw WN, Shields JE, Slieker LJ, Su KS, Sundell KL, Chance RE: Synthesis of a fast-acting insulin based on structural homology with insulin-like growth factor I. In Peptides XII (Proceedings of the 12th American Peptide Symposium). Smith J, Rivier J, Eds. Leiden, Netherlands, ESCOM Science Publishing B.V., 1992, p. 26-28
14. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR: [Lys(B28), Pro(B29)]-Human insulin: a rapidly absorbed analogue of human insulin. Diabetes 43:396-402, 1994
15. Torlone E, Fanelli C, Rambotti AM, Kassi G, Modarelli F, DiVincenzo A, Epifano L, Ciofetta M, Pampanelli S, Brunetti P, Bolli GB: Pharmacokinetics, pharmacodynamics, and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28), Pro(B29)] in IDDM. Diabetologia 37:713-720, 1994
16. Tuominen JA, Karonen SL, Melamies L, Bolli G, Koivisto VA: Exercise-induced hypoglycemia in IDDM patients treated with a short-acting insulin analogue. Diabetologia 38:106-111, 1995
17. World Health Organization: WHO Expert Committee on Diabetes Mellitus: 2nd Report,. Geneva, World Health Organization, 1980 (Tech. Rep. Ser. No. 646)
18. Howey DC, Bowsher RR, Brunelle RL, Rowe HM, Santa PF; Downing-Shelton J, Woodworth JR: [Lys(B28), Pro(B29)]-human insulin: effect of injection time on postprandial glycemia, Clin Pharmacol Ther 58:459-469, 1995
19. Hoffmeister H, Junge B: Über die Haltbarkeit von Serumbestandteilen und die Zuverlassigkeit ihrer Bestimmung im Autoanalyzer SMA 12-30 Survey. Z Klin Chem Klin Biochem 8:613-617, 1970
20. 1c by high performance cation exchange chromatography. Clin Chem 26:3-7, 1980
21. Koch GG: The use of non-parametric methods in the statistical analysis of the two-period change-over design. Biometrics 28:577-584, 1972
22. Taulbee JD: A note on the use of nonparametric methods in the statistical analysis of the two-period changeover design. Biometrics 38:1053-1055, 1982
23. The DCCT Research Group: Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 90:450-459, 1991
24. Pramming S, Thorsteinsson B, Bendtson I, Binder C: The relationship between symptomatic and biochemical hypoglycemia in insulin-dependent diabetic patients. J Int Med 228:641-646, 1990
25. Antsiferov M, Woodworth JR, Mayorov A, Ristic S, Dedov I: Within patient variability in postprandial glucose excursion with Lispro insulin analog compared with regular insulin (Abstract). Diabetologia 38 (Suppl. 1):A190, 1995
26. Cryer PE: Iatrogenic hypoglycemia in IDDM: consequences, risk factors and prevention. In Diabetes Annual. Vol. 7. Marshall SM, Home PD, Alberti KGMM, Krall LP, Eds. Amsterdam, Elsevier, 1993, p. 317-331
27. Wredling RAM, Theorell PGT, Roll HM, Lins PES, Adamson UKC: Psychosocial state of patients with IDDM prone to recurrent episodes of severe hypoglycemia. Diabetes Care 15:518-520, 1992
28. Gale EAM, Tattersall RB: Unrecognized nocturnal hypoglycemia in insulin-treated diabetics. Lancet 1:1049-1052, 1979
29. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, DiVincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P, Porcellati F, Scionti L, Santeusanio F, Brunetti P, Bolli GB: Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 42:1683-1689, 1993
30. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA: Restoration of hypoglycaemia awareness in patients with long-duration insulin dependent diabetes. Lancet 344:283-287, 1994
31. De Veciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, Evans AT: Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 333:1237-1241, 1995
32. Nielsen FS, Jørgensen LN, Ipsen M, Voldsgaard AI, Parving HH: Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen. Diabetologia 38:592-598, 1995
33. Fineberg SE, Fineberg NS, Anderson JH, Birkett M: Insulin immune response to lyspro human insulin therapy in insulin naive type I and type II patients (Abstract). Diabetologia 38 (Suppl. 1):A4, 1995
34. Buelke-Sam J, Byrd RA, Hoyt JA, Zimmerman JL: A reproductive and developmental toxicity study in CD rats of LY275585, (Lys(B28), Pro(B29))-human insulin. J Am Coll Toxicol 13:247-260, 1994
35. Slieker LJ, Brooke GS, Chance RE, Fan L, Hoffmann JA, Howey DC, Long HB, Mayer J, Shields JE, Sundell KL, DiMarchi RD: Insulin and IGF-I analogs: novel approaches to improved insulin pharmacokinetics. In Current Directions in Insulin-like Growth Factor Research. LeRoith D, Raizada MK, Eds. New York, Plenum Press, 1994, p. 25-32